Premium
Integer Holdings Corporation (ITGR)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -479,00 | 42,23k | Derivative Exercise and Sale | 88,16 | 5,85k | - |
| 2026-05-15 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | 1,48k | 0,00 | Derivative Exercise and Retained Stock | - | 5,85k | 33,97% |
| 2026-05-08 | Mr. Diron SmithExec. VP & CFO | -503,00 | 44,32k | Derivative Exercise and Sale | 88,12 | 12,92k | - |
| 2026-05-08 | Mr. Diron SmithExec. VP & CFO | 1,56k | 0,00 | Derivative Exercise and Retained Stock | - | 12,92k | 13,73% |
| 2026-03-31 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | -1,84k | 162,10k | Derivative Exercise and Sale | 88,00 | 8,66k | - |
| 2026-03-31 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 2,00k | 0,00 | Derivative Exercise and Retained Stock | - | 8,66k | 29,95% |
| 2026-03-24 | Mr. Tony CarrExec. VP of Global Quality & Regulatory Affairs | -398,00 | 34,30k | Derivative Exercise and Sale | 86,19 | 952,00 | - |
| 2026-03-24 | Mr. Tony CarrExec. VP of Global Quality & Regulatory Affairs | 952,00 | 0,00 | Derivative Exercise and Retained Stock | - | 952,00 | - |
| 2026-03-24 | Ms. Lindsay Krause BlackwoodSenior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | -1,05k | 90,41k | Derivative Exercise and Sale | 86,19 | 2,43k | - |
| 2026-03-24 | Ms. Lindsay Krause BlackwoodSenior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary | 2,43k | 0,00 | Derivative Exercise and Retained Stock | - | 2,43k | - |
| 2026-03-13 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -825,00 | 70,13k | Vente | 85,00 | 4,38k | -15,85% |
| 2026-02-20 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -656,00 | 55,66k | Sale to Issuer | 84,85 | 4,37k | -13,06% |
| 2026-02-20 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | -2,20k | 186,50k | Sale to Issuer | 84,85 | 34,98k | -5,91% |
| 2026-02-20 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -713,00 | 60,50k | Sale to Issuer | 84,85 | 5,21k | -12,05% |
| 2026-02-20 | Mr. Andrew SennPresident of Cardio & Vascular | -1,45k | 122,78k | Sale to Issuer | 84,85 | 14,81k | -8,90% |
| 2026-02-24 | Mr. Payman KhalesCEO, President & Director | 26,12k | 0,00 | Derivative Exercise and Retained Stock | - | 61,85k | 73,07% |
| 2026-02-24 | Mr. Payman KhalesCEO, President & Director | -16,95k | 1,48M | Derivative Exercise and Sale | 87,10 | 61,85k | - |
| 2026-02-20 | Mr. Payman KhalesCEO, President & Director | -4,64k | 393,53k | Sale to Issuer | 84,85 | 61,85k | -6,98% |
| 2026-02-20 | Mr. Diron SmithExec. VP & CFO | -394,00 | 33,43k | Sale to Issuer | 84,85 | 11,36k | -3,35% |
| 2026-01-17 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | 461,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,06k | 12,82% |
| 2026-01-19 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -334,00 | 28,56k | Derivative Exercise and Sale | 85,15 - 85,78 | 4,06k | - |
| 2026-01-17 | Mr. Diron SmithExec. VP & CFO | 2,44k | 0,00 | Derivative Exercise and Retained Stock | - | 10,14k | 31,70% |
| 2026-01-19 | Mr. Diron SmithExec. VP & CFO | -920,00 | 78,87k | Derivative Exercise and Sale | 85,15 - 85,78 | 10,14k | - |
| 2026-01-17 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 596,00 | 0,00 | Derivative Exercise and Retained Stock | - | 6,66k | 9,83% |
| 2026-01-19 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | -552,00 | 47,35k | Derivative Exercise and Sale | 85,78 | 6,66k | - |
| 2026-01-17 | Mr. Payman KhalesCEO, President & Director | 2,61k | 0,00 | Derivative Exercise and Retained Stock | - | 25,47k | 11,40% |
| 2026-01-19 | Mr. Payman KhalesCEO, President & Director | -962,00 | 82,31k | Derivative Exercise and Sale | 85,15 - 85,78 | 25,47k | - |
| 2026-01-17 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | 1,06k | 0,00 | Derivative Exercise and Retained Stock | - | 2,33k | 83,12% |
| 2026-01-17 | Mr. Jim StephensPresident of Cardiac Rhythm Management & Neuromodulation | -447,00 | 38,34k | Derivative Exercise and Sale | 85,78 | 2,33k | - |
| 2026-01-17 | Mr. Andrew SennPresident of Cardio & Vascular | 2,13k | 0,00 | Derivative Exercise and Retained Stock | - | 11,54k | 22,66% |
| 2026-01-19 | Mr. Andrew SennPresident of Cardio & Vascular | -1,09k | 92,62k | Derivative Exercise and Sale | 85,15 - 85,78 | 11,54k | - |
| 2026-01-17 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | 1,47k | 0,00 | Derivative Exercise and Retained Stock | - | 28,16k | 5,49% |
| 2026-01-19 | Mr. Kirk K. ThorExec. VP & Chief HR Officer | -595,00 | 50,90k | Derivative Exercise and Sale | 85,15 - 85,78 | 28,16k | - |
| 2026-01-02 | Ms. Pamela G. BaileyInitié | 1,08k | 52,50k | Derivative Exercise and Retained Stock | 48,43 | 54,25k | 2,04% |
| 2026-01-02 | Ms. Pamela G. BaileyInitié | -1,80k | 52,53k | Derivative Exercise and Sale | 48,43 - 77,63 | 54,25k | - |
| 2025-12-12 | Mr. M. Craig MaxwellIndependent Director | 969,00 | 46,93k | Derivative Exercise and Retained Stock | 48,43 | 22,38k | 4,53% |
| 2025-12-12 | Mr. M. Craig MaxwellIndependent Director | -1,91k | 46,98k | Derivative Exercise and Sale | 48,43 - 72,98 | 22,38k | - |
| 2025-11-12 | Mr. John HarrisExec. VP of Global Operations & Manufacturing Strategy | 1,65k | 115,50k | Achat | 70,00 | 6,07k | 37,36% |
| 2025-11-11 | Mr. Tom P. ThomasVP, Corporate Controller & Principal Accounting Officer | -884,00 | 62,01k | Vente | 70,15 | 3,60k | -19,73% |
| 2025-11-07 | Mr. Diron SmithExec. VP & CFO | 1,12k | 74,97k | Achat | 67,19 | 7,70k | 16,95% |
| 2025-11-06 | Ms. Cheryl C. CappsIndependent Director | 1,60k | 106,72k | Achat | 66,70 | 10,57k | 17,84% |
| 2025-10-30 | Mr. Payman KhalesCEO, President & Director | 3,13k | 203,07k | Achat | 64,94 | 22,87k | 15,84% |
| 2025-06-11 | Mr. Joseph W. DziedzicInitié | 22,81k | 0,00 | Derivative Exercise and Retained Stock | - | 45,81k | 99,16% |
| 2025-06-11 | Mr. Joseph W. DziedzicInitié | -13,40k | 1,61M | Derivative Exercise and Sale | 120,03 | 45,81k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
